Skip to main content
Top
Published in: Breast Cancer Research 1/2017

Open Access 01-12-2017 | Erratum

Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis

Authors: Arumugam Nagalingam, Jack L. Arbiser, Michael Y. Bonner, Neeraj K. Saxena, Dipali Sharma

Published in: Breast Cancer Research | Issue 1/2017

Login to get access

Excerpt

After the publication of this work [1], an error was noticed in Fig. 1b. An incorrect image was inadvertently shown for the soft-agar colony for MDA-MB-231 cells treated with 5.0 uM Honokiol. The correct figure is shown below. This error did not affect the findings or conclusions of the article.
Literature
1.
go back to reference Nagalingam A, et al. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res. 2012;14(1):R35.CrossRefPubMedPubMedCentral Nagalingam A, et al. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res. 2012;14(1):R35.CrossRefPubMedPubMedCentral
Metadata
Title
Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis
Authors
Arumugam Nagalingam
Jack L. Arbiser
Michael Y. Bonner
Neeraj K. Saxena
Dipali Sharma
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2017
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-017-0829-2

Other articles of this Issue 1/2017

Breast Cancer Research 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine